No need to delay skin surgery after isotretinoin treatment
Expert panel finds no evidence of excess risk from most procedures during drug therapy Related items fromOnMedica Monthly testing with isotretinoin might be unnecessary
Authors: Wan Kim Y PMID: 28730797 [PubMed - in process]
Authors: Altundag K PMID: 28730796 [PubMed - in process]
Authors: Vlad C, Kubelac P, Alexandru I, Achimas-Cadariu P PMID: 28730795 [PubMed - in process]
Authors: Anastasakis A, Zafeirakis P, Livir-Rallatos C, Livir-Rallatos G PMID: 28730794 [PubMed - in process]
Authors: Altundag K PMID: 28730792 [PubMed - in process]
Authors: Lv M, Kou B, Zhou ZL, He WB Abstract This paper addresses a problem for assignment of chemo-receiving inpatients in an oncology care center, which has not been addressed in the literature. Chemotherapy is regarded as one of the most effective treatments for cancer. In recent years, as cancer incidence increased, the number of patients admitted to a cancer treatment center has also been rising. How to balance the workload of medical service resources by planning admission of patients has become an essential problem that must be given consideration by policy- makers. The allocation of chemotherapy patients, ...
CONCLUSION: We suggest that perioperative systemic chemotherapy serves as a helpful therapeutic tool in the management of peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery &HIPEC. PMID: 28730790 [PubMed - in process]
Authors: Adam C, Patiraki E, Lemonidou C, Radwin L, Charalambous A, Charalambous M, Berg A, Sjövall K, Katajisto J, Stolt M, Suhonen R Abstract PURPOSE: To explore and compare cancer patients' perceptions on the quality of nursing care in four European countries. METHODS: Data were collected in Cyprus, Finland, Greece and Sweden. The sample comprised 596 hospitalized cancer patients. The quality of nursing care was measured using the "Oncology Patients' Perceptions of the Quality of Nursing Care Scale" (OPPQNCS). Patient characteristics were also collected. Analysis of variance was used to examin...
CONCLUSIONS: Topo I overexpression is observed in a significant subset of LSCCs affecting the level of differentiation in them. Additional molecular studies focused on the mechanism of Topo I gene/protein deregulation (i.e. amplification, abnormal epigenetic promoter methylation, mRNA aberrant expression) are necessary discriminating the eligible patients for applying specific chemotherapeutic strategies based on anti-Topo I agents. PMID: 28730788 [PubMed - in process]
CONCLUSIONS: Ferritin is a potential urinary biomarker to discriminate between PCa and BPH patients. PMID: 28730787 [PubMed - in process]